Previous Page  52 / 172 Next Page
Information
Show Menu
Previous Page 52 / 172 Next Page
Page Background

Atul Ltd | Annual Report 2015-16

Pharmaceuticals

Product groups: API intermediates, Active Pharmaceutical Ingredients, Others

The products falling under these product groups are used by customers belonging to Pharmaceutical industry for various

therapeutic categories, such as anti-depressant, anti-diabetic, anti-infective, anti-retroviral and cardiovascular. The product

groups comprise about 50 products. Carbonates, chloroformates, isocyanates and organic ureas are some of the key classes of

products.

During 2015-16, sales decreased by 1% from

`

334 cr to

`

330 cr. Sales in India

decreased by 9% from

`

186 cr to

`

170 cr. Sales outside India increased by 8%

from

`

148 cr to

`

160 cr and formed 48% of the total. Degrowth on account

of volume was 1%. The Company successfully completed its second USFDA

inspection for one of its products; it is in the process of expanding its API plant.

Atul Bioscience Ltd (ABL), a 100% subsidiary company, focussed on production

of advanced API intermediates, increased its sales by 17% from

`

47 cr to

`

55 cr, primarily because of volume; it undertook 1 project for implementation.

The size of world Pharmaceutical industry is estimated at US$ 1.75 tn, of

which the conventional pharmaceutical segment is US$ 1.2 tn and is growing

at about 8%. Of this, the size of world API industry is estimated at US$ 150 bn and is growing at about 7%. There are about 20

major companies which dominate the world marketplace.

The main user industry, namely, Pharmaceutical, is growing well because of increasing awareness about diseases and health.

The Company along with ABL will participate in this growth by i) widening its market reach, ii) increasing its manufacturing

efficiencies, iii) generating

and adding capacities and iv)

introducing new products.

It will also form long-term

strategic alliances with other

companies.

The prices of some products

may come down in a short

time. Fluctuations in foreign

exchange may impact sales

realisations.

Performance and Other Chemicals Segment

Particulars

2015-16

2014-15

% Change

Sales (

`

cr)

1,659

1,834

(10)%

Share in total sales (%)

69%

73%

(4)%

Performance and Other Chemicals Segment consists 4 Sub-segments, namely, Aromatics, Bulk Chemicals and Intermediates,

Colors and Polymers.